Evidence map›Paper›PMID 25939402›Full record

ArticleMolecular psychiatry2015

Small molecules demonstrate the role of dynamin as a bi-directional regulator of the exocytosis fusion pore and vesicle release.

J Jackson, A Papadopulos, F A Meunier, A McCluskey, P J Robinson, D J Keating

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. BaPharmacology research & perspectives · 2025
    Article
  3. Chlamydia trachomatis invasion: a duet of effectors.Biochemical Society transactions · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. SNARE-Mediated Exocytosis in Neuronal Development.Frontiers in molecular neuroscience · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Dynamin 1 Restrains Vesicular Release to a Subquantal Mode In Mammalian Adrenal Chromaffin Cells.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  17. Dynamic L-type CaBiochimica et biophysica acta. Molecular cell research · 2018
    Article
  18. How does the stimulus define exocytosis in adrenal chromaffin cells?Pflugers Archiv : European journal of physiology · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

J JacksonDiscipline of Human Physiology, Centre for Neuroscience, Flinders University, Adelaide, Australia.
A PapadopulosClem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
F A MeunierClem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
A McCluskeyCentre for Chemical Biology and Chemistry, School of Environmental and Life Sciences, The University of Newcastle, Callaghan, New South Wales, Australia.
P J RobinsonChildren's Medical Research Institute, University of Sydney, Westmead, New South Wales, Australia.
D J Keating1] Discipline of Human Physiology, Centre for Neuroscience, Flinders University, Adelaide, Australia [2] South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia.
Park Centre for Mental Health · AUChildren's Medical Research Institute · AUFlinders University · AUSouth Australian Health and Medical Research Institute · AUUniversity of Newcastle Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hormones and neurotransmitters are stored in specialised vesicles and released from excitable cells through exocytosis. During vesicle fusion with the plasma membrane, a transient fusion pore is created that enables transmitter release. The protein dynamin is known to regulate fusion pore expansion (FPE). The mechanism is unknown, but requires its oligomerisation-stimulated GTPase activity. We used a palette of small molecule dynamin modulators to reveal bi-directional regulation of FPE by dynamin and vesicle release in chromaffin cells. The dynamin inhibitors Dynole 34-2 and Dyngo 4a and the dynamin activator Ryngo 1-23 reduced or increased catecholamine released from single vesicles, respectively. Total internal reflection fluorescence (TIRF) microscopy demonstrated that dynamin stimulation with Ryngo 1-23 reduced the number of neuropeptide Y (NPY) kiss-and-run events, but not full fusion events, and slowed full fusion release kinetics. Amperometric stand-alone foot signals, representing transient kiss-and-run events, were less frequent but were of longer duration, similarly to full amperometric spikes and pre-spike foot signals. These effects are not due to alterations in vesicle size. Ryngo 1-23 action was blocked by inhibitors of actin polymerisation or myosin II. Therefore, we demonstrate using a novel pharmacological approach that dynamin not only controls FPE during exocytosis, but is a bi-directional modulator of the fusion pore that increases or decreases the amount released from a vesicle during exocytosis if it is activated or inhibited, respectively. As such, dynamin has the ability to exquisitely fine-tune transmitter release.

Indexed as

AnimalsCatecholaminesCells, CulturedChromaffin CellsCyanoacrylatesDynaminsExocytosisHydrazonesIndolesKineticsMaleMice, Inbred C57BLMicroscopy, FluorescenceNaphtholsNeuropeptide YSecretory VesiclesCatecholaminesCyanoacrylatesDynaminsdyngo-4adynole 34-2HydrazonesIndolesNaphtholsNeuropeptide YRyngo 1-23Tyrphostins

Identifiers

PMID25939402
OpenAlexW1484670943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.